Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Boyapalle, Sandhya ^a,b,c   Wong, Terianne ^b,c   Garay, Julio ^b,c   Teng, Michael ^d   San Juan Vergara, Homero ^c,f   Mohapatra, Subhra ^a,b,c,e   Mohapatra, Shyam ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Department of Internal Medicine   (United States)

^d Department of Allergy and Immunology ^*  (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f UNIVERSIDAD DEL NORTE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NONSTRUCTURAL PROTEIN 1; OUTER MEMBRANE PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; ALPHA INTERFERON; BETA INTERFERON; RARRES3 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRUS PROTEIN; VISA PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOPRECIPITATION; INTERFERON PRODUCTION; MITOCHONDRION; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL LINE; CONFOCAL MICROSCOPY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; METHODOLOGY; PLASMID; PROTEIN BINDING; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-ALPHA; INTERFERON-BETA; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MICROSCOPY, IMMUNOELECTRON; PLASMIDS; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84857603541     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029386     Document Type: Article

References (37)

1. Wong DT, Ogra PL, (1983) Viral infections in immunocompromised patients. Med Clin North Am 67: 1075-1092.
2. Ebbert JO, Limper AH, (2005) Respiratory Syncytial Virus Pneumonitis in Immunocompromised Adults: Clinical Features and Outcome. Respiration 72: 263-269.
3. Blanchard SS, Gerrek M, Siegel C, Czinn SJ, (2006) Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: Case report and discussion regarding need of routine prophylaxis. Pediatric Transplantation 10: 826-829.
4. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
5. Becker Y, (2006) Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy- a review. Virus Genes 33: 235-252.
6. Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC 3rd, et al. (1994) Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 68: 5321-5325.
7. Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA, (1990) Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8: 497-502.
8. Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, et al. (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15: 34-41.
9. DeVincenzo J, Cehelsky JE, Alvarez R, Elbashir S, Harborth J, et al. (2008) Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Research 77: 225-231.
10. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, et al. (2010) A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proceedings of the National Academy of Sciences 107: 8800-8805.
11. Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, et al. RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus. Am J Respir Crit Care Med pp. 201003-200422OC.
12. Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, et al. (2005) Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 11: 56-62.
13. Bitko V, Musiyenko A, Shulyayeva O, Barik S, (2005) Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 11: 50-55.
14. Kong X, Zhang W, Lockey RF, Auais A, Piedimonte G, et al. (2007) Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet Vaccines Ther 5: 4.
15. Kumar M, Behera A, Matsuse H, Lockey R, Mohapatra S, (1999) Intranasal IFN-gamma gene transfer protects BALB/c mice against respiratory syncytial virus infection. Vaccine 18: 558-567.
16. Tran KC, Collins PL, Teng MN, (2004) Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo. J Virol 78: 692-699.
17. Mohapatra SS, Boyapalle S, (2008) Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin Microbiol Rev 21: 495-504.
18. Kong X, San Juan H, Kumar M, Behera AK, Mohapatra A, et al. (2003) Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochemical and Biophysical Research Communications 306: 616-622.
19. Schlender J, Bossert B, Buchholz U, Conzelmann KK, (2000) Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol 74: 8234-8242.
20. Lo MS, Brazas RM, Holtzman MJ, (2005) Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Mediate Inhibition of Stat2 Expression and Alpha/Beta Interferon Responsiveness. J Virol 79: 9315-9319.
21. Spann KM, Tran KC, Collins PL, (2005) Effects of Nonstructural Proteins NS1 and NS2 of Human Respiratory Syncytial Virus on Interferon Regulatory Factor 3, NF-{kappa}B, and Proinflammatory Cytokines. J Virol 79: 5353-5362.
22. Munir S, Le Nouen C, Luongo C, Buchholz UJ, Collins PL, et al. (2008) Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. Journal of Virology 82: 8780-8796.
23. Ling Z, Tran KC, Teng MN, (2009) Human Respiratory Syncytial Virus Nonstructural Protein NS2 Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-I. Journal of Virology 83: 3734-3742.
24. Bitko V, Shulyayeva O, Mazumder B, Musiyenko A, Ramaswamy M, et al. (2007) Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF-κB-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth. Journal of Virology 81: 1786-1795.
25. Ling Z, Tran KC, Arnold JJ, Teng MN, (2008) Purification and characterization of recombinant human respiratory syncytial virus nonstructural protein NS1. Protein Expr Purif 57: 261-270.
26. Krishnan B, Szymanska A, Gierasch LM, (2007) Site-specific Fluorescent Labeling of Poly-histidine Sequences Using a Metal-chelating Cysteine. Chemical Biology & Drug Design 69: 31-40.
27. Hainfeld JF, Liu W, Halsey CMR, Freimuth P, Powell RD, (1999) Ni-NTA-Gold Clusters Target His-Tagged Proteins. Journal of Structural Biology 127: 185-198.
28. Boyapalle S, Beckett RJ, Pal N, Miller WA, Bonning BC, (2008) Infectious genomic RNA of Rhopalosiphum padi virus transcribed in vitro from a full-length cDNA clone. Virology 375: 401-411.
29. Knecht S, Ricklin D, Eberle AN, Ernst B, (2009) Oligohis-tags: mechanisms of binding to Ni2+-NTA surfaces. Journal of Molecular Recognition 22: 270-279.
30. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
31. Seth RB, Sun L, Ea C-K, Chen ZJ, (2005) Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-[kappa]B and IRF3. Cell 122: 669-682.
32. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, et al. (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36: 263-269.
33. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
34. Egger D, Bienz K, (2005) Intracellular location and translocation of silent and active poliovirus replication complexes. J Gen Virol 86: 707-718.
35. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, et al. (2007) Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 81: 1401-1411.
36. Swedan S, Andrews J, Majumdar T, Musiyenko A, Barik S, (2011) Multiple Functional Domains and Complexes of the Two Nonstructural Proteins of Human Respiratory Syncytial Virus Contribute to Interferon Suppression and Cellular Location. J Virol 85: 10090-10100.
37. Horner SM, Liu HM, Park HS, Briley J, Gale M Jr, (2011) Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A 108: 14590-14595.